Ever since taking up the role of WWE's Chief Content Officer, Triple H has mostly delivered with his major storylines. The majority of the fans have been extremely content with Triple H's booking for ...

A 20-year-old student battling blood cancer in Bhubaneswar faces a dire financial situation. His family, struggling to afford the escalating treatment costs exceeding their Rs 5 lakh insurance limit, ...

Iberdomide, combined with Darzalex and dexamethasone, improves MRD negativity in relapsed multiple myeloma, showcasing CELMoDs' potential in treatment. Early-stage blood cancer diagnosis and ...

This year’s V/H/S film is particularly exciting to us nerds at Nerdist. As you all know, we are massive Halloween fans and, each year, we love to do our own celebration of all things spooky for our ...

You can’t turn on the TV without seeing ads for glucose-lowering GLP-1 drugs like Ozempic and Wegovy. A1C numbers are cocktail-party chatter. Helpful? Sure. But almost nobody knows the chemistry ...

Beta-thalassemia is a genetic disorder that significantly burdens healthcare systems globally. This inherited blood disorder, categorized into beta-thalassemia and alpha-thalassemia, results in ...

The Hollywood landmark has hosted blood drives since 2014. Donors do a good deed, but the perk is entry into the private club. Credit... Supported by By Nicole Stock Visuals by Maggie Shannon ...

The bloodstained assault rifle used by gunman Shane Tamura during his deadly rampage inside a Midtown skyscraper Monday night is shown in shocking detail in photos obtained by The Post. The Palmetto ...

Novartis AG (NYSE:NVS) on Thursday released results from APPULSE-PNH, a Phase 3B study evaluating the efficacy and safety of twice-daily oral monotherapy Fabhalta (iptacopan) in adult patients with ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information by sharing relevant background and reasoning ...

ON HOW IT APPROVES VACCINES. WELL, YOU CAN SAY GOODBYE TO THOSE FINGER --. THE RED CROSS IS REVOLUTIONIZING THE WAY WE DONATE BLOOD WITH THE BRAND NEW -- FREE TEST. NO MORE NEEDLES BEFORE YOU DONATE.

Plus: Newton’s CyberArk clears $1 billion in revenue; MassCEC launches climate-tech strategy for state; EMK Institute draws lobbyist with Trump ties It all started with an essay contest. Rob Blood’s ...